Adalimumab biosimilar Cyltezo gets interchangeability designationOctober 18, 2021Rheumatoid ArthritisSpondyloarthropathiesPediatricsPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Synthetic chemical in consumer products linked to early death, study saysOctober 12, 2021PediatricsMixed Topics
Acceptance of biosimilars grows but greater use may hinge on switching, interchangeability studiesSeptember 30, 2021Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesPediatricsAnkylosing spondylitisLupus & Connective Tissue Diseases
Dr. Judy C. Washington shows URM physicians how to leadSeptember 30, 2021Diversity in MedicineBusiness of MedicinePediatrics
European agency recommends two new adalimumab biosimilarsSeptember 20, 2021Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Three JAK inhibitors get boxed warnings, modified indicationsSeptember 2, 2021Rheumatoid ArthritisPsoriatic ArthritisPediatrics
Tocilizumab shortage continues as pandemic wears onAugust 19, 2021Rheumatoid ArthritisLupus & Connective Tissue DiseasesCOVID-19 UpdatesPediatrics
Hep B vaccine response varied among youth with inflammatory, autoimmune disordersAugust 12, 2021Pediatrics
HBV screening often incomplete or forgone when starting tocilizumab, tofacitinibAugust 9, 2021Rheumatoid ArthritisPediatricsPsoriatic ArthritisLupus & Connective Tissue Diseases
